Navigation Links
ELECTRA 1400C Coagulation System

ProductsELECTRA 1400C Coagulation System
Company Beckman Coulter, Inc.
Item ELECTRA 1400C Coagulation System
Features 
  • Simultaneous execution of clotting and chromogenic assays in random access
  • Extended walkaway capabilities with 35 sample positions for routine and 3 positions available for STAT
  • Integrated barcode reader ensures accurate patient identification
  • Sample liquid level sensing with customized needle setting of the maximum depth
  • Walkaway with 280 reaction cuvettes on board
  • 4 refrigerated reagent positions for clotting and chromogenic assays; and 13 additional positions for controls, calibrators, deficient plasma and diluents
  • Customized Quality Control Program allows storage, retrieval and manipulation of patient data
  • Advanced, intuitive computer technology that offers full alpha-numeric capabilities and standard ASTM communication that allows for easy interface with LIS/HIS systems
Description The advanced features of the ELECTRA 1400C are designed to achieve low daily operational costs with extended walkaway capabilities. This system includes automated primary tube sampling and performs APTT, PT, fibrinogen and factor assays in a single setup. It also has an integrated barcode reader and automatic preparation of reference curves and patient sample dilutions to ensure accuracy. Plus, it can perform both clotting and chromogenic testing in random access.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. ACL 100 Coagulation Analyzer
2. Electra 1800C Coagulation System
3. ACL Advance Coagulation Analyzer
4. ACL 9000 Coagulation Analyzer
5. Automated Blood Coagulation Analyzer
6. MLA Electra 750 Coagulation Analyzer
7. Cascade M Manual Coagulation Analyzer
8. Cascade M-4 Manual Coagulation Analyzer
9. Blood Coagulation Analyzer CG Series
10. Non-Stick Bipolar Coagulation Forceps
11. ACT PLUS Automated Coagulation Timer System
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology: